Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy



Status:Recruiting
Conditions:Skin and Soft Tissue Infections, Infectious Disease, Neurology, Nephrology
Therapuetic Areas:Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Nephrology / Urology, Neurology
Healthy:No
Age Range:18 - Any
Updated:2/1/2019
Start Date:March 13, 2017
End Date:June 18, 2021
Contact:Recruiting sites have contact information. Please contact the sites directly. If there is no contact information,
Email:Clinical.Trials@bms.com
Phone:please email:

Use our guide to learn which trials are right for you!

A Phase 3, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC With Standard Treatment Compared to Standard Treatment Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy (IIM)

Trial to Evaluate the Efficacy and Safety of Abatacept subcutaneous (SC) in Combination With
Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults
With Active Idiopathic Inflammatory Myopathy


For more information regarding Bristol-Myers Squibb Clinical Trial participation, please
visit www.BMSStudyConnect.com

Inclusion Criteria:

-Diagnosis of IIM based on the Bohan and Peter classification criteria: i) Subjects with
dermatomyositis (DM) must also have a confirmed myositis-associated rash (Gottron's papules
or a heliotrope rash preferably confirmed by skin biopsy) and 2 or more of the remaining 4
criteria.

ii) Subjects with a diagnosis of IIM other than DM include PM, autoimmune necrotizing
myopathy, myositis in association with another connective tissue disease (overlap myositis)
and juvenile myositis subjects above the age of 18. These subjects must have a prior muscle
biopsy diagnostic for IIM or a positive test for at least one myositis-specific
autoantibody (anti-aminoacyl-tRNA synthetases (Jo-1, PL-7, PL-12, EJ, OJ, KS, Zo, YRS),
anti-Mi-2, anti-SRP, anti-TIF1-g, anti-NXP-2, anti-MDA5, anti-SAE, anti-HMGCR). For
subjects with overlap myositis, the myositis must be the principal clinically active
manifestation of their disease. Where applicable, documentation of prior skin biopsy,
muscle biopsy, and autoantibody results must be obtained and retained by the site.

- Demonstrable muscle weakness measured by the MMT-8 of ≤ 135 units and any 3 of the
following: i) MMT-8 ≤ 125 units; ii) Physician's global assessment (PGA) visual analog
scale (VAS) ≥2 cm; iii) Subject's global assessment (SGA) VAS ≥2 cm; iv) HAQ-DI ≥ 0.5;
v) One or more muscle enzyme (CK, aldolase, LDH, AST, ALT) ³ 1.3 times upper limit of
normal (ULN); vi) MDAAT Extramuscular Global Activity VAS ≥2 cm

- Demonstration of currently active IIM will be determined by an adjudication committee
unless the subject has any one of the following: i) an active myositis-associated rash
(Gottron's papules or heliotrope rash), or ii) a recent (within 3 months prior to
signing informed consent) biopsy, magnetic resonance imaging (MRI), or electromyogram
(EMG) demonstrating active disease, or iii) an elevated CK > 5 times the upper limit
of normal

- Active disease despite prior treatment with corticosteroids, immunosuppressants, or
biologics as determined by the investigator

- The subject must be on background standard treatment for IIM. The standard treatments
that are allowed as background treatment for IIM includes: i) Corticosteroids alone,
or ii) One of the following immunosuppressants: methotrexate, azathioprine,
mycophenolate mofetil, tacrolimus, or cyclosporine (combinations of these treatments
are not allowed), or iii) A combination of corticosteroids and one of the above
immunosuppressants. The subject must have been on the same medication(s) for IIM for
12 weeks prior to randomization and the dose must have been stable for 4 weeks prior
to randomization. If using azathioprine, the subject must have been on azathioprine
for at least 24 weeks with a stable dose for at least 12 weeks prior to randomization.

Exclusion Criteria:

- Subjects with Inclusion Body Myositis (IBM), or myositis other than IIM, eg,
drug-induced myositis and PM associated with HIV

- Subjects treated with penicillamine or zidovudine in the past 3 months

- Subjects treated with rituximab in the 6 months prior to randomization (there must be
laboratory results indicating the presence of circulating B cells [CD19+]). Any other
biologic treatment in the past 3 months or immune globulin (intravenous [IVIG] or
subcutaneous [SCIG]) in the past 3 months prior to randomization

- Subjects with uncontrolled or rapidly progressive interstitial lung disease

- Subjects with severe muscle damage (Myositis Damage Index > 7/10), permanent weakness
due to a non-IIM cause, or myositis with cardiac involvement

- Cancer-associated myositis (myositis diagnosed within 2 years of a diagnosis of cancer

- Subjects who are known to be positive for the anti-TIF-1 (p155/140) autoantibody prior
to randomization who were diagnosed with IIM < 1 year prior to randomization.

- Subjects at risk for tuberculosis

- Subjects with recent acute infection requiring antibiotics

- Subjects with history of chronic or recurrent bacterial, viral or systemic fungal
infections

- Subjects who have a present malignancy or have had a previous malignancy within the
last 5 years prior to screening (except for a documented history of cured
non-metastatic squamous or basal cell skin carcinoma or cervical carcinoma in situ).

Other protocol defined inclusion/exclusion criteria could apply
We found this trial at
32
sites
Orangeburg, South Carolina 29118
Phone: 803-539-2224
?
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Miami, Florida 33136
Phone: 305-243-8567
?
mi
from
Miami, FL
Click here to add this to my saved trials
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Austin, Texas 78756
?
mi
from
Austin, TX
Click here to add this to my saved trials
Baltimore, Maryland 21237
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bethlehem, Pennsylvania 18015
Phone: 6108681336123
?
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Beverly Hills, California 90211
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Boston, Massachusetts 02115
Phone: 617-525-6763
?
mi
from
Boston, MA
Click here to add this to my saved trials
Bronx, New York 10467
?
mi
from
Bronx, NY
Click here to add this to my saved trials
Camperdown, New South Wales 2050
?
mi
from
Camperdown,
Click here to add this to my saved trials
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Dallas, Texas 75246
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Eagan, Minnesota 55121
Phone: 651-361-8659
?
mi
from
Eagan, MN
Click here to add this to my saved trials
Fort Lauderdale, Florida 33309
?
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Fullerton, California 92835
?
mi
from
Fullerton, CA
Click here to add this to my saved trials
Houston, Texas 77030
Phone: 713-795-0033
?
mi
from
Houston, TX
Click here to add this to my saved trials
Jackson, Tennessee 38305
Phone: 731-633-0045
?
mi
from
Jackson, TN
Click here to add this to my saved trials
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
Lebanon, New Hampshire 03756
Phone: 603-653-0492
?
mi
from
Lebanon, NH
Click here to add this to my saved trials
Los Angeles, California 90095
Phone: 310-825-4744
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Middleburg Heights, Ohio 44130
Phone: 440-826-0742
?
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Norman, Oklahoma 73069
Phone: 405-701-2466
?
mi
from
Norman, OK
Click here to add this to my saved trials
Emile St
Omaha, Nebraska 68198
(402) 559-4000
Phone: 402-559-8140
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
?
mi
from
Omaha, NE
Click here to add this to my saved trials
?
mi
from
Orange, CA
Click here to add this to my saved trials
Phoenix, Arizona 85016
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phoenix, Arizona 85028
Phone: 48031410076
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
3550 Terrace Street
Pittsburgh, Pennsylvania 15261
Phone: 412-648-9989
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Phone: 314-362-1626
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Upland, California 91786
?
mi
from
Upland, CA
Click here to add this to my saved trials
Washington, District of Columbia 20037
Phone: 202-677-6141
?
mi
from
Washington,
Click here to add this to my saved trials
Wilmington, North Carolina 28401
Phone: 91076211821022
?
mi
from
Wilmington, NC
Click here to add this to my saved trials